rs776761421
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_001999.4(FBN2):c.7553C>T(p.Pro2518Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,613,548 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001999.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152058Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251086Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135672
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461490Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727064
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152058Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74266
ClinVar
Submissions by phenotype
not provided Uncertain:3
The FBN2 c.7553C>T; p.Pro2518Leu variant (rs776761421), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 578249). This variant is found in the general population with an overall allele frequency of 0.0012% (3/251086 alleles) in the Genome Aggregation Database. Computational analyses predict that this variant is deleterious (REVEL: 0.759). Due to limited information, the clinical significance of this variant is uncertain at this time. -
- -
Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Although located in a calcium-binding EGF-like domain of the FBN2 gene, it does not substitute or introduce a cysteine residue (Callewaert et al., 2009; Frederic et al., 2009) -
Familial thoracic aortic aneurysm and aortic dissection Uncertain:1
The p.P2518L variant (also known as c.7553C>T), located in coding exon 59 of the FBN2 gene, results from a C to T substitution at nucleotide position 7553. The proline at codon 2518 is replaced by leucine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Congenital contractural arachnodactyly Uncertain:1
This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 2518 of the FBN2 protein (p.Pro2518Leu). This variant is present in population databases (rs776761421, gnomAD 0.003%). This missense change has been observed in individuals with thoracic aortic aneurysm and/or dissection (internal data). ClinVar contains an entry for this variant (Variation ID: 578249). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed for this missense variant. However, the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on FBN2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at